Intersect-then-combine approach: improving the performance of somatic variant calling in whole exome sequencing data using multiple aligners and callers
暂无分享,去创建一个
Carlos Caldas | Oscar M. Rueda | Suet-Feung Chin | Alejandra Bruna | S. Chin | C. Caldas | O. Rueda | S. Sammut | M. Callari | A. Bruna | L. De Mattos-Arruda | Maurizio Callari | Leticia De Mattos-Arruda | Stephen-John Sammut
[1] N. Rosenfeld,et al. The somatic mutation profiles of 2,433 breast cancers refines their genomic and transcriptomic landscapes , 2016, Nature Communications.
[2] Terence P. Speed,et al. Comparing somatic mutation-callers: beyond Venn diagrams , 2013, BMC Bioinformatics.
[3] J. Zook,et al. Integrating human sequence data sets provides a resource of benchmark SNP and indel genotype calls , 2013, Nature Biotechnology.
[4] Salvatore Piscuoglio,et al. Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasma , 2015, Nature Communications.
[5] R. Wilson,et al. Cancer genome sequencing: a review. , 2009, Human molecular genetics.
[6] H. Hakonarson,et al. Low concordance of multiple variant-calling pipelines: practical implications for exome and genome sequencing , 2013, Genome Medicine.
[7] C Caldas,et al. Consensus on precision medicine for metastatic cancers: a report from the MAP conference. , 2016, Annals of oncology : official journal of the European Society for Medical Oncology.
[8] John W. Cassidy,et al. A Biobank of Breast Cancer Explants with Preserved Intra-tumor Heterogeneity to Screen Anticancer Compounds , 2016, Cell.
[9] Mads Thomassen,et al. Evaluation of Nine Somatic Variant Callers for Detection of Somatic Mutations in Exome and Targeted Deep Sequencing Data , 2016, PloS one.
[10] Joshua M. Stuart,et al. The Cancer Genome Atlas Pan-Cancer analysis project , 2013, Nature Genetics.
[11] Ravi Vijaya Satya,et al. Comparison of somatic mutation calling methods in amplicon and whole exome sequence data , 2014, BMC Genomics.
[12] J. Zook,et al. An analytical framework for optimizing variant discovery from personal genomes , 2015, Nature Communications.
[13] R. Wilson,et al. The Next-Generation Sequencing Revolution and Its Impact on Genomics , 2013, Cell.
[14] Joshua M. Stuart,et al. Combining tumor genome simulation with crowdsourcing to benchmark somatic single-nucleotide-variant detection , 2015, Nature Methods.
[15] Trevor J Pugh,et al. Discovery and characterization of artifactual mutations in deep coverage targeted capture sequencing data due to oxidative DNA damage during sample preparation , 2013, Nucleic acids research.
[16] Michael C. Heinold,et al. A comprehensive assessment of somatic mutation detection in cancer using whole-genome sequencing , 2015, Nature Communications.
[17] Lawrence D. True,et al. Integrative Clinical Genomics of Advanced Prostate Cancer , 2015, Cell.
[18] Wendy S. W. Wong,et al. Strelka: accurate somatic small-variant calling from sequenced tumor-normal sample pairs , 2012, Bioinform..
[19] G. McVean,et al. A reference data set of 5.4 million phased human variants validated by genetic inheritance from sequencing a three-generation 17-member pedigree , 2016, bioRxiv.
[20] S Beck,et al. RPS6KA2, a putative tumour suppressor gene at 6q27 in sporadic epithelial ovarian cancer , 2007, Oncogene.
[21] Gil McVean,et al. A reference dataset of 5.4 million phased human variants validated by genetic inheritance from sequencing a three-generation 17-member pedigree , 2016 .
[22] R. Daniel Kortschak,et al. A comparative analysis of algorithms for somatic SNV detection in cancer , 2013, Bioinform..